| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2992657 | Journal of Vascular Surgery | 2011 | 11 Pages |
Abstract
This Phase I study has demonstrated safety, and the AFS rates suggest efficacy of ABMNC in promoting limb salvage in “no option” CLI. Based on these results, we plan to test the concept that ABMNCs improve AFS at 1 year in a Phase III randomized, double-blinded, multicenter trial.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael P. MD, Jeffrey H. MD, PhD, Brian M. MD, Michael C. MD, Janet RN, Michael G. PhD, Gary D. PhD, Keith L. MD, PhD,